Web Desc
Brain Therapeutics: Disruptive Technologies and Opportunities
joint with Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus
Scientific Organizers: Maria-Jesus Blanco, Kalpana M. Merchant and Mabel Loza
Date: February 16 - 19, 2020
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Supported by the Directors' Fund
Summary of Meeting:
CNS disorders represent a major unmet medical need with an associated societal burden that is becoming unsustainable due to changing demographics (e.g., aging population). In response to these burdens, major investments in basic and translational research have been made by government and non-profit institutions world-wide. However, despite these efforts, pharmaceutical companies and equity investors continue to view brain therapeutics as a relatively risky area of investment. This Keystone Symposia conference aims to highlight breakthrough technologies and approaches to de-risk CNS-targeted therapies. More importantly, with the proposed agenda and invited speakers, an aim is to demonstrate how that integration of cross-disciplinary knowledge and approaches has the potential to overcome the contemporary challenges of CNS drug development. One of the unique features of this conference is that it brings together scientists from a range of disciplines, who rarely participate in the same meetings, in order to create an environment that can lead to disruptive innovation. Invited speakers will provide a general overview, as well as in-depth technical presentations, to engage the participants in numerous topics, such as disease biology-informed target selection, novel medicinal chemistry approaches, biomarkers, and clinical trial designs. Advances in technologies such as genomics, imaging and brain delivery will be highlighted throughout. The speakers on the program represent public and private sectors, young and established scientists and world-wide geography. This conference aspires to create an interdisciplinary environment where new collaborations will form that could continue well beyond the conference itself and help address the unmet medical need of CNS disorders. Finally, this meeting is being paired with the Keystone Symposia conference on Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus. The goal of this paring is to stimulate cross-disciplinary thinking about CSF-based medicinal therapies.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: October 29 2019 details
Discounted Abstract Deadline: October 29 2019 details & pricing
Abstract Deadline: November 19 2019 details & pricing
Discounted Registration Deadline: December 17 2019 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for short talks. Abstracts may be submitted for poster presentations up to 6 weeks prior to meeting start date based on availability


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Vincere Biosciences, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found